Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Rebecca S Pettit"'
Publikováno v:
SAGE Open Medicine, Vol 5 (2017)
Objectives: Previous studies have examined renal safety of once daily intravenous tobramycin in individuals with cystic fibrosis. This has been mainly in combination with ceftazidime in an adolescent or adult population. In this report, we describe o
Externí odkaz:
https://doaj.org/article/413fc8f07f1f4cab9088344ccc01c2c3
Publikováno v:
Pediatric Pulmonology. 58:1092-1099
Patients with cystic fibrosis (CF) may be treated with piperacillin-tazobactam (PZT) for acute pulmonary exacerbations. Extending the infusion of PZT is one strategy to increase efficacy. Direct comparison, with respect to incidence of acute kidney i
Publikováno v:
Pediatric Pulmonology. 57:919-925
Pediatric cystic fibrosis (CF) patients possess unique pharmacokinetics and may benefit from prolonged beta-lactam infusions to optimize pharmacodynamics. This study compared adverse drug event (ADE) rates with cefepime prolonged (PI) and standard in
Autor:
Hanna Phan, Michelle Condren, Mohsain Gill, Rebecca S. Pettit, Wendy Palmrose, Corinne A. Muirhead, Shannon M. Rotolo
Publikováno v:
Pediatric Pulmonology. 56:2879-2887
Introduction To help open the clinician dialogue regarding cannabis use in persons with CF in the U.S., we aimed to describe current practices of use assessment and documentation processes related to cannabis. Methods A cross sectional, anonymous sur
Publikováno v:
Pediatric Pulmonology. 56:2861-2867
BACKGROUND Cystic fibrosis (CF) patients who grow Pseudomonas aeruginosa on respiratory culture are commonly prescribed inhaled tobramycin (TIS) to eradicate the organism. The objective of this study was to determine the impact of a pharmacy technici
Publikováno v:
Annals of Pharmacotherapy. 56:181-192
Objective: To review the available literature addressing alternative allergic bronchopulmonary aspergillosis (ABPA) treatment options for patients with cystic fibrosis (CF). Data Sources: A literature search of PubMed was performed (January 2002 to A
Autor:
Rachel Hagyeong Yang, Julie W. Stephens, Rebecca S. Pettit, Kristin Wiisanen, Roseann S. Gammal, D. Max Smith, Henry M. Dunnenberger, Joseph M. Cusimano, Christine M. Walko
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4:652-658
Publikováno v:
Pediatric Pulmonology. 55:2662-2666
Background Individuals with cystic fibrosis (CF) require higher dosages of aminoglycosides due to an increased volume of distribution (Vd ) and clearance. Optimal dosing of aminoglycosides in the CF population is essential as repeated exposure to ami
Autor:
Bernard Lee, Amy L. Potts, Tracy Sandritter, Joseph M. LaRochelle, Sandra Benavides, Allison M. Chung, Rebecca S. Pettit, Kelly Bobo, David C Knoppert, Katherine P. Smith, Tracy M. Hagemann, Audrey Kennedy, Kalen B. Manasco, Hanna Phan, Elizabeth Farrington
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3:786-792
Autor:
Emily Belarski, Rebecca S. Pettit
Publikováno v:
Pediatric Pulmonology. 55:654-659
Objective Methicillin-resistant Staphylococcus aureus (MRSA) infections in cystic fibrosis (CF) patients have greatly increased in prevalence in the past two decades and may lead to a more rapid rate of lung function decline. The objective of this st